Company: EHC
Filing Date: 2025-02-21
Form Type: 8-K
Source: 0000785161-25-000006
Chunk: 0

Company: Encompass Health Corp
Filing Date: 2025-02-21
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Compensatory Arrangements of Certain Officers.

At regularly scheduled meetings on February 19-20, 2025, the Board of Directors (the “ Board”) of Encompass Health Corporation (the “ Corporation”) and its Compensation and Human Capital Committee (the “ Committee”) undertook the customary review and approval of annual compensation decisions. The Board approved, at the recommendation of the Committee and its independent consultant, the compensation increases for 2025 as set forth in the table below for Mr. Mark Tarr, President and Chief Executive Officer. The Board also approved an increase in Mr. Tarr’s annual allowance for personal usage of the Corporation’s aircraft from approximately $75,000 to $100,000. Additionally, the Committee approved the compensation increases for 2025 for the three other named executive officers as set forth in the table below.

                                                                         Base Salary      Target Cash Bonus Award Opportunity      Target Long-term Equity Award Opportunity  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Mark J. Tarr                                                 2024       $1,050,000                               $1,260,000                                     $5,425,000  
  President and Chief Executive Officer                        2025       $1,100,000                               $1,485,000                                     $6,000,000  
  Douglas E. Coltharp                                          2024         $700,000                                 $595,000                                     $1,925,000  
  Executive Vice President and Chief Financial Officer         2025         $750,000                                 $750,000                                     $2,250,000  
  Patrick Darby                                                2024         $625,000                                 $468,750                                     $1,031,250  
  Executive Vice President, General Counsel and Secretary      2025         $625,000                                 $500,000                                     $1,093,750  
  Elissa J. Charbonneau, D. O.                                 2024         $415,000                                 $207,500                                       $456,500  
  Chief Medical Officer                                        2025         $435,000                                 $261,000                                       $478,500  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report